financetom
Business
financetom
/
Business
/
--Comcast Keeps Quarterly Dividend at $0.33 a Share, Payable July 23 to Shareholders of Record July 2
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Comcast Keeps Quarterly Dividend at $0.33 a Share, Payable July 23 to Shareholders of Record July 2
May 26, 2025 11:48 AM

11:42 AM EDT, 05/21/2025 (MT Newswires) --

Price: 35.54, Change: -0.05, Percent Change: -0.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
RTX Unit Raytheon Wins $1.1 Billion US Navy Contract for AIM-9X Missile Production
RTX Unit Raytheon Wins $1.1 Billion US Navy Contract for AIM-9X Missile Production
Jun 4, 2025
08:32 AM EDT, 06/04/2025 (MT Newswires) -- RTX (RTX) said Wednesday that its Raytheon unit has been awarded a $1.1 billion contract from the US Navy to produce AIM-9X Block II missiles. The company said the contract will boost annual production to 2,500 missiles. The AIM-9X is an infrared-guided short-range missile that can be used in both air-to-air and surface-to-air...
Thrive-backed accounting firm Crete to spend $500 million in AI roll-up
Thrive-backed accounting firm Crete to spend $500 million in AI roll-up
Jun 4, 2025
* Crete PA's revenue exceeds $300 million with 20 firms acquired * Thrive partners with OpenAI for customized accounting tools * Venture capital targets traditional services for AI-driven growth By Krystal Hu June 4 - Crete Professionals Alliance, an accounting platform backed by Thrive Capital, plans to invest over $500 million to acquire U.S.-based accounting firms in the next two...
Sagimet's Partner Achieves Positive Results With Oral Acne Drug In Phase 3 Trial In China, Stock Jumps
Sagimet's Partner Achieves Positive Results With Oral Acne Drug In Phase 3 Trial In China, Stock Jumps
Jun 4, 2025
Sagimet Biosciences Inc. ( SGMT ) said on Wednesday that denifanstat met all primary and secondary endpoints in a Phase 3 trial for moderate to severe acne vulgaris. The trial was conducted by Sagimet’s license partner, Ascletis Bioscience Co. Ltd., in China. Denifanstat is a once-daily oral small-molecule fatty acid synthase (FASN) inhibitor being developed by Ascletis as ASC40 for acne...
AECOM Receives US Air Force Engineering, Support Contract Worth up to $1.5 Billion
AECOM Receives US Air Force Engineering, Support Contract Worth up to $1.5 Billion
Jun 4, 2025
08:26 AM EDT, 06/04/2025 (MT Newswires) -- AECOM ( ACM ) said Wednesday it has been selected by the US Air Force Civil Engineer Center to provide architecture and engineering services through a multiple-award task order contract with a $1.5 billion ceiling. The contract includes restoration, conservation, planning and environmental quality maintenance for the Air Force and other federal agencies,...
Copyright 2023-2025 - www.financetom.com All Rights Reserved